News

Search EMA's news announcements

Resultat (3827)

EMA receives application for conditional marketing authorisation for Paxlovid (PF-07321332 and ritonavir) for treating patients with COVID-19

10 januari 2022

NewsHumanCOVID-19Medicines

Emer Cooke’s end-of-year message

22 december 2021

NewsCorporateCOVID-19

EMA recommends Nuvaxovid for authorisation in the EU

20 december 2021

NewsHumanCOVID-19Vaccines

EMA working on COVID-19 over holiday period

20 december 2021

NewsHumanCorporateCOVID-19

EMA Management Board: highlights of December 2021 meeting

17 december 2021

NewsCorporate

Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 13-16 December 2021

17 december 2021

NewsHumanCOVID-19Medicines

New treatment for sickle cell disease

17 december 2021

NewsHumanMedicines

EMA issues advice on use of Paxlovid (PF-07321332 and ritonavir) for the treatment of COVID-19: rolling review starts in parallel

16 december 2021

NewsHumanCOVID-19Medicines

Increase in manufacturing capacity for COVID-19 vaccines from Janssen, Moderna and BioNTech/Pfizer

16 december 2021

NewsHumanCOVID-19Vaccines

COVID-19: EMA recommends authorisation of antibody medicine Xevudy

16 december 2021

NewsHumanCOVID-19Medicines